BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27179908)

  • 1. MicroRNA let-7d is a target of cannabinoid CB1 receptor and controls cannabinoid signaling.
    Chiarlone A; Börner C; Martín-Gómez L; Jiménez-González A; García-Concejo A; García-Bermejo ML; Lorente M; Blázquez C; García-Taboada E; de Haro A; Martella E; Höllt V; Rodríguez R; Galve-Roperh I; Kraus J; Guzmán M
    Neuropharmacology; 2016 Sep; 108():345-52. PubMed ID: 27179908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cocaine modulates the expression of opioid receptors and miR-let-7d in zebrafish embryos.
    López-Bellido R; Barreto-Valer K; Sánchez-Simón FM; Rodríguez RE
    PLoS One; 2012; 7(11):e50885. PubMed ID: 23226419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered gene expression and functional activity of opioid receptors in the cerebellum of CB1 cannabinoid receptor knockout mice after acute treatments with cannabinoids.
    Páldyová E; Bereczki E; Sántha M; Wenger T; Borsodi A; Benyhe S
    Acta Biol Hung; 2007; 58 Suppl():113-29. PubMed ID: 18297798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons: implications for Huntington's disease.
    Laprairie RB; Kelly ME; Denovan-Wright EM
    Neuropharmacology; 2013 Sep; 72():47-57. PubMed ID: 23602984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor.
    Klegeris A; Bissonnette CJ; McGeer PL
    Br J Pharmacol; 2003 Jun; 139(4):775-86. PubMed ID: 12813001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission.
    Kim J; Li Y
    J Physiol; 2015 Feb; 593(4):871-86. PubMed ID: 25504573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A restricted population of CB1 cannabinoid receptors with neuroprotective activity.
    Chiarlone A; Bellocchio L; Blázquez C; Resel E; Soria-Gómez E; Cannich A; Ferrero JJ; Sagredo O; Benito C; Romero J; Sánchez-Prieto J; Lutz B; Fernández-Ruiz J; Galve-Roperh I; Guzmán M
    Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8257-62. PubMed ID: 24843137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of BiP as a CB
    Costas-Insua C; Moreno E; Maroto IB; Ruiz-Calvo A; Bajo-Grañeras R; Martín-Gutiérrez D; Diez-Alarcia R; Vilaró MT; Cortés R; García-Font N; Martín R; Espina M; Botta J; Ginés S; McCormick PJ; Sánchez-Prieto J; Galve-Roperh I; Mengod G; Urigüen L; Marsicano G; Bellocchio L; Canela EI; Casadó V; Rodríguez-Crespo I; Guzmán M
    J Neurosci; 2021 Sep; 41(38):7924-7941. PubMed ID: 34353897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid CB1 receptors are expressed in the mouse urinary bladder and their activation modulates afferent bladder activity.
    Walczak JS; Price TJ; Cervero F
    Neuroscience; 2009 Mar; 159(3):1154-63. PubMed ID: 19356696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
    Dowie MJ; Bradshaw HB; Howard ML; Nicholson LF; Faull RL; Hannan AJ; Glass M
    Neuroscience; 2009 Sep; 163(1):456-65. PubMed ID: 19524019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
    Schatz AR; Lee M; Condie RB; Pulaski JT; Kaminski NE
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):278-87. PubMed ID: 9070350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CB2 cannabinoid receptors promote mouse neural stem cell proliferation.
    Molina-Holgado F; Rubio-Araiz A; García-Ovejero D; Williams RJ; Moore JD; Arévalo-Martín A; Gómez-Torres O; Molina-Holgado E
    Eur J Neurosci; 2007 Feb; 25(3):629-34. PubMed ID: 17328768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentiviral-mediated let-7d microRNA overexpression induced anxiolytic- and anti-depressant-like behaviors and impaired dopamine D3 receptor expression.
    Bahi A; Dreyer JL
    Eur Neuropsychopharmacol; 2018 Dec; 28(12):1394-1404. PubMed ID: 30244920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids.
    Carriba P; Ortiz O; Patkar K; Justinova Z; Stroik J; Themann A; Müller C; Woods AS; Hope BT; Ciruela F; Casadó V; Canela EI; Lluis C; Goldberg SR; Moratalla R; Franco R; Ferré S
    Neuropsychopharmacology; 2007 Nov; 32(11):2249-59. PubMed ID: 17356572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of opioid and cannabinoid receptor genes in human neuroblastoma and T cells by the epigenetic modifiers trichostatin A and 5-aza-2'-deoxycytidine.
    Börner C; Martella E; Höllt V; Kraus J
    Neuroimmunomodulation; 2012; 19(3):180-6. PubMed ID: 22262103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interactive role of CB(1) and GABA(B) receptors in hippocampal synaptic plasticity in rats.
    Nazari M; Komaki A; Karamian R; Shahidi S; Sarihi A; Asadbegi M
    Brain Res Bull; 2016 Jan; 120():123-30. PubMed ID: 26611204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid CB1 receptor and serotonin 3 receptor subunit A (5-HT3A) are co-expressed in GABA neurons in the rat telencephalon.
    Morales M; Wang SD; Diaz-Ruiz O; Jho DH
    J Comp Neurol; 2004 Jan; 468(2):205-16. PubMed ID: 14648680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents.
    Álvaro-Bartolomé M; García-Sevilla JA
    Neuroscience; 2013 Sep; 247():294-308. PubMed ID: 23727505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors.
    Martín AB; Fernandez-Espejo E; Ferrer B; Gorriti MA; Bilbao A; Navarro M; Rodriguez de Fonseca F; Moratalla R
    Neuropsychopharmacology; 2008 Jun; 33(7):1667-79. PubMed ID: 17957223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures.
    Molina-Holgado F; Molina-Holgado E; Guaza C; Rothwell NJ
    J Neurosci Res; 2002 Mar; 67(6):829-36. PubMed ID: 11891798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.